Green RP-HPLC methods for assay and related substances in rivaroxaban tablets

• Autorzy: Nakov Natalija , Anastasova Liljana , Gjorgievska Marija Zafirova , Acevska Jelena , Brezovska Katerina , Petkovska Rumenka , Dimitrovska Aneta

Identyfikatory

DOI

10.1556/1326.2023.01178

• Języki publikacji: EN

Abstrakty

EN

In this study, two different ethanol-based RP-HPLC methods for assay and quantification of rivaroxaban related substances in tablets were developed, based on green analytical chemistry (GAC) principles, using the design of experiments approach. The chromatographic separation was performed on X-Bridge C18 column (250 3 4.6 mm, 5 μm particle size), using isocratic elution with ethanol : water (35:65, % v/v) for the assay and gradient elution with ethanol/water mobile phase, for related substances, with a flow rate of 1.0 mL min_1. The gradient method was optimized for the separation of three specified impurities (impurity G, impurity H, and impurity 14) and the selectivity was further confirmed using forced degradation studies. Both methods were validated in accordance with ICH guidelines. The robustness of the methods was confirmed with the Central Composite Face Design of Experiments. Analytical Eco-scale approach and AGREE metrics confirmed that both methods are in accordance with the GAC principles. The proposed ethanol-based RP-HPLC methods were applied for assay and determination of related substances in rivaroxaban 10 mg tablets obtained from three different manufacturers available on the Macedonian market.

Słowa kluczowe

EN

rivaroxaban; green analytical chemistry; ethanol-based HPLC method; greenness evaluation; pharmaceutical analysis

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2024
• Tom: Vol. 36, no. 4
• Strony: 371--382
• Opis fizyczny: Bibliogr. 24 poz., tab., wykr.

Twórcy

autor

Nakov Natalija

• Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

• https://orcid.org/0000-0002-2221-9850

autor

Anastasova Liljana

• Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

autor

Gjorgievska Marija Zafirova

• Center for Drug Quality Control, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

autor

Acevska Jelena

• Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

autor

Brezovska Katerina

• Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

autor

Petkovska Rumenka

• Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

autor

Dimitrovska Aneta

• Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia

Bibliografia

• 1. Yabré, M.; Ferey, L.; Touridomon Somé, I.; Sivadier, G.; Gaudin, K. J. Pharm. Biomed. Anal. 2020, 190, 113507.
• 2. Kokilambigai, K. S.; Lakshmi, K. S. J. Chrom. Open 2022, 2, 100052.
• 3. Nakov,N.; Acevska, J.; Brezovska, K.;Kavrakovski,Z.; Dimitrovska, A. In High Performance Liquid Chromatography – Recent Advances and Applications; Nú_nez, O., Sentellas, S., Granados, M., Saurina, J., Eds. IntechOpen: London, 2023; pp 119–40.
• 4. Rao, W.; Li, L.; Zhang, C.; Zheng, J.; Fan, J.; Luan, B.; Sun, J.; Qui, M.; Wu, S.; Li, Y.; Wang, Z. J. Pharm. Biomed. Anal. 2023, 228, 115325.
• 5. Stojanovic, J.; Krmar, J.; Otasevic, B.; Protic, A. Arh. Farm. 2023, 73, 146–71.
• 6. Bonde, A. N.; Marinussen, T.; Lee, C. J.; Lip, G. Y. H.; Staerk, L.; Bang, C.; Bhattacharya, J.; Gislason, G.; Torp-Pedersen, C.; Olesen, J. B.; Hlatky, M. A. Circ. Cardiovasc. Qual. Outcomes 2020, 13, e006058.
• 7. Lim, G. B. Nat. Rev. Cardiol. 2020, 17, 320.
• 8. Malik, A. H.; Yandrapalli, S.; Shetty, S.; Frishman, W. H.; Aronow, W. S. Am J. Ther. 2022, 29(3), e373–6.
• 9. Berger, J. S.; Connors, J. M. The Lancet 2021, 397(10291), 2226–8.
• 10. Kumar, D.; Kaimaparambil, V.; Chandralekha, S.; Lalchandani. J. Assoc. Physicians India 2022, 70(2), 11–2.
• 11. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonized Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2(R1). ICH, 2005. https://www.ema.europa.eu/documents/scientific-guideline/ich-q-2-r1-validation-analytical-procedures-text-methodology-step-5_en.pdf.
• 12. Deidda, R.; Orlandini, S.; Hubert, P.; Hubert, C. J. Pharm. Biomed. Anal. 2018, 161, 110–21.
• 13. European Pharmacopoeia. General monographs: rivaroxaban tablets. 11th Ed. 2022–2023. Strasbourg France: European Directorate for the quality of medicines & Healthcare, 3904–6.
• 14. United States Pharmacopeia USP Monographs, Rivaroxaban Tablets. USP-NF; United States Pharmacopeia: Rockville, MD, 2023.
• 15. Reçber, T.; Haznedaro_glu, C. I.; Çelebier, M. Crit. Rev. Anal. Chem. 2020, 1–13.
• 16. Arous, B.; Al-Mardini, M. A.; Karabet, F.; Daghestani, M.; Al-Lahham, F.; Al-Askar, A. Pharm. Chem. J. 2018, 52, 483–90.
• 17. Ramisetti, R. N.; Kuntamukkala, R. RSC Adv. 2014, 4, 23155–67.
• 18. Rao, W.; Li, L.; Zhang, C.; Zheng, J.; Fan, X.; Luan, B.; Sun, J.; Qui, M.; Wu, S.; Li, Y.; Wang, Z. J. Pharm. Biomed. Anal 2023, 228, 115325.
• 19. Alam, I.; Ali, N. S.; Qayoom, A.; Bibi, R.; Aqeel, M.; Muhammad, H. Microchem. J. 2023, 193, 109025.
• 20. European Pharmacopoeia draft chater 5.33 design of experiments (PA/PH/Exp. SDA/T (22) 4 ANP), Pharmeuropa 34.4 | October 2022, 7-15, Strasbourg France: European Directorate for the quality of medicines & Healthcare.
• 21. Gałuszka, A.; Konieczka, P.; Migaszevski, Z. M.; Namie_snik, J. TrAC 2012, 37, 61–72.
• 22. Pena-Pereira, F.; Wojnowski, W.; Tobiszevski, M. Anal. Chem. 2020, 92, 10076–82.
• 23. Turner, C. Pure Appl. Chem. 2013, 85, 2217–29.
• 24. Çelebier, M.; Reçber, T.; Koçak, E.; Altınöz, S. Braz. J. Pharm. Sci. 2013, 49, 359–66, 2013.